Who
Kristen K. Buck
EVP, R&D and CMO
Company insider
Files Form 4 as: EVP, R&D and CMO, Lisata Therapeutics.
In numbers
- Trades disclosed
- 39
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 1 Sep 2021
- Last trade
- 9 Jan 2026
- Last filed
- 13 Jan 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 9 Jan 2026filed 13 Jan 2026 | LSTA Lisata TherapeuticsBiotechnology | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 9 Jan 2026filed 13 Jan 2026 | LSTA Lisata TherapeuticsBiotechnology | SEC FORM 4 Code F | $5,8752,982 at $1.97 | filing |
| 9 Jan 2026filed 13 Jan 2026 | LSTA Lisata TherapeuticsBiotechnology | SEC FORM 4 Code F | $5,8752,982 at $1.97 | filing |
| 9 Jan 2026filed 13 Jan 2026 | LSTA Lisata Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —13,000 at $0.00 | filing |
| 9 Jan 2026filed 13 Jan 2026 | LSTA Lisata TherapeuticsBiotechnology | SEC FORM 4 Code F | $6,3453,221 at $1.97 | filing |
| 9 Jan 2026filed 13 Jan 2026 | LSTA Lisata TherapeuticsBiotechnology | SEC FORM 4 Code F | $4,2302,147 at $1.97 | filing |
| 9 Jan 2026filed 13 Jan 2026 | LSTA Lisata Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —13,000 at $0.00 | filing |
| 9 Jan 2026filed 13 Jan 2026 | LSTA Lisata TherapeuticsBiotechnology | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 9 Jan 2026filed 13 Jan 2026 | LSTA Lisata TherapeuticsBiotechnology | SEC FORM 4 Code F | $5,8752,982 at $1.97 | filing |
| 9 Jan 2026filed 13 Jan 2026 | LSTA Lisata TherapeuticsBiotechnology | SEC FORM 4 Code F | $5,8752,982 at $1.97 | filing |
| 9 Jan 2026filed 13 Jan 2026 | LSTA Lisata TherapeuticsBiotechnology | SEC FORM 4 Code F | $6,3453,221 at $1.97 | filing |
| 9 Jan 2026filed 13 Jan 2026 | LSTA Lisata TherapeuticsBiotechnology | SEC FORM 4 Code F | $4,2302,147 at $1.97 | filing |
| 10 Jan 2025filed 13 Jan 2025 | LSTA Lisata TherapeuticsBiotechnology | SEC FORM 4 Code F | $1,701456 at $3.73 | filing |
| 9 Jan 2025filed 13 Jan 2025 | LSTA Lisata Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —13,000 at $0.00 | filing |
| 9 Jan 2025filed 13 Jan 2025 | LSTA Lisata TherapeuticsBiotechnology | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 9 Jan 2025filed 13 Jan 2025 | LSTA Lisata TherapeuticsBiotechnology | SEC FORM 4 Code F | $10K2,651 at $3.80 | filing |
| 9 Jan 2025filed 13 Jan 2025 | LSTA Lisata TherapeuticsBiotechnology | SEC FORM 4 Code F | $11K2,863 at $3.80 | filing |
| 9 Jan 2025filed 13 Jan 2025 | LSTA Lisata TherapeuticsBiotechnology | SEC FORM 4 Code F | $7,2501,908 at $3.80 | filing |
| 1 Oct 2024filed 2 Oct 2024 | LSTA Lisata TherapeuticsBiotechnology | SEC FORM 4 Code A | $44K15,000 at $2.93 | filing |
| 1 Oct 2024filed 2 Oct 2024 | LSTA Lisata TherapeuticsBiotechnology | SEC FORM 4 Code F | $19K6,363 at $2.93 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.